NEW YORK (GenomeWeb) – BioReference Laboratories today reported that its second quarter revenues increased 14 percent year over year, growth that it partly attributed to its genetics testing business.

The Elmwood Park, NJ-based clinical lab brought in total revenues of $201.4 million for the three months ended April 30, up from $176.5 million for the second quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.